Esra French, MD, MBA is a Clinical Associate Professor of Medicine at UPMC Division of Diabetes and Endocrinology. As Clinical Chief of Endocrinology, she organizes multidisciplinary teams with physicians, physician assistants, diabetes educators and nurses to improve access to diabetes care in Western PA. She partners with health plan and develop diabetes population health strategies like e-consults to improve diabetes outcomes

 

 

Clinical Education Coordinator, Clinical Training & Education, UPMC Health Plan

 

Program Manager, Clinical Training & Education, UPMC Health Plan

​

AVP, Medicaid Medical Services, UPMC Health Plan

 

 

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated.

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.